News On Graf Acquisition Corp. IV (GFOR) Now Under NKGN
News On Graf Acquisition Corp. IV (GFOR) Now Under NKGN
Press Release: Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 25, 2023
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023 PR Newswire THE WOODLANDS, Texas, Sept. 22, 2023 TH
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 20, 2023
THE WOODLANDS, Texas, Sept. 14, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS)) (the "Company" or "Graf"), announced today that on September 13, 2023, it adjourned, without
Press Release: Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 13, 2023
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 13, 2023 PR Newswire THE WOODLANDS, Texas, Sept. 11, 2023 TH
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 8, 2023
THE WOODLANDS, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR-UN, GFOR-WT)) (the "Company" or "Graf"), announced today that it intends to adjourn, without conducting any business,
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
NKGen Biotech Inc. and Graf Acquisition Corp. IV to Co-Host Investor Event
SANTA ANA, Calif. and THE WOODLANDS, Texas, July 06, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. ("NKGen"), a clinical-stage biotechnology company focused on the development and commercialization of innovative
NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination With Graf Acquisition Corp. IV
Express News | Graf Acquisition Corp. IV and NKGen Biotech, Inc. Intent Letter of Intent for a Business Intent
Graf Acquisition Corp. IV (OTCMKTS:GFORU) Stock Price Up 0.8%
Graf Acquisition Corp. IV (OTCMKTS:GFORU – Get Rating)'s stock price shot up 0.8% on Thursday . The stock traded as high as $10.18 and last traded at $10.18. 700 shares changed hands during trading, T
Graf Acquisition Corp. IV Withdraws Extension Proposal
Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS)) (the "Company") today announced that it is withdrawing from the ballot for its special meeting of stockholders to be held on December 21, 2022 (the "Special
Graf Acquisition Corp. IV (OTCMKTS:GFORU) Trading Down 0.3%
Shares of Graf Acquisition Corp. IV (OTCMKTS:GFORU – Get Rating) were down 0.3% during mid-day trading on Wednesday . The stock traded as low as $9.90 and last traded at $9.90. Approximately 100 shar
Graf Acquisition Corp. IV (OTCMKTS:GFORU) Shares Up 0.3%
Shares of Graf Acquisition Corp. IV (OTCMKTS:GFORU – Get Rating) shot up 0.3% on Tuesday . The company traded as high as $9.80 and last traded at $9.80. 100 shares changed hands during mid-day tradin
Graf Acquisition Corp. IV (OTCMKTS:GFORU) Trading Up 0.1%
Graf Acquisition Corp. IV (OTCMKTS:GFORU – Get Rating) shares were up 0.1% on Monday . The company traded as high as $9.88 and last traded at $9.76. Approximately 4,186 shares changed hands during tr
Graf Acquisition Corp. IV (NYSE:GFOR) Is Definitely on the Radar of Institutional Investors Who Own 48% of the Company
Graf Acquisition Corp. IV (OTCMKTS:GFORU) Stock Price Up 0.3%
Graf Acquisition Corp. IV (OTCMKTS:GFORU – Get Rating) shares rose 0.3% during trading on Thursday . The stock traded as high as $9.76 and last traded at $9.75. Approximately 34,177 shares were trade
Graf Acquisition Corp. IV (OTCMKTS:GFORU) Trading Down 0.1%
Graf Acquisition Corp. IV (OTCMKTS:GFORU – Get Rating) shares were down 0.1% during mid-day trading on Wednesday . The stock traded as low as $9.78 and last traded at $9.78. Approximately 4,801 share
Graf Acquisition Corp. IV Shares Open For Trade At $9.93; IPO Priced At $10/Unit
Graf Acquisition Corp. IV Shares Open For Trade At $9.93; IPO Priced At $10/Unit
No Data